The number of CD4+CD25+FoxP3+Tregs in peripheral blood decreases during the more severe stages of anti-AChR antibody-positive MG and increases with treatment [92], with significantly lower levels in generalized anti-AChR MG without thymoma than in ocular MG [93]. This evidence concerns the gene CD4 and myasthenia gravis.